968 top medical experts on Systemic Scleroderma across 60 countries and 35 U.S. states, including 867 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Systemic Scleroderma: A chronic multi-system disorder of connective tissue. It is characterized by sclerosis in the skin, the lungs, the heart, the gastrointestinal tract, the kidneys, and the musculoskeletal system. Other important features include diseased small blood vessels and autoantibodies. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: limited scleroderma and diffuse scleroderma.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Skin Diseases (3,308), Connective Tissue Diseases (1,572) and Narrower Categories: Diffuse Scleroderma (2,180), Limited Scleroderma (1,084).
  4. Clinical Trials ClinicalTrials.gov : at least 463 including 23 Active, 216 Completed, 90 Recruiting
  5. Synonyms: Systemic Sclerosis


  

        

                    


    Computing Expert Listing ...

);